Enanta Pharmaceuticals Inc.
ENTA | NASDAQ
$12.42
+$0.31 (+2.56%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -19.5M | -13.09M | -11.94M | -18.7M | -18.26M | -22.64M | -22.29M | -28.82M | -22.66M | -31.16M | -33.41M | -28.11M | -39.07M | -37.66M | -28.99M | -26.35M | -31.7M | -33.59M | -30.12M | -24.6M | -24.02M | -22.05M | -8.33M |
Depreciation & Amortization | 1.5M | 1.21M | 1.25M | 1.28M | 1.21M | 1.2M | 889K | 479K | 594K | 621K | 642K | 669K | 651K | 540K | 511K | 655K | 716K | 822K | 780K | 806K | 823K | 834K | 871K |
Stock-Based Compensation | 3.68M | 3.75M | 3.81M | 4.03M | 4.18M | 4.69M | 5.67M | 7.72M | 5.42M | 5.56M | 8.1M | 6.72M | 7M | 7.36M | 7.14M | 6.83M | 7.6M | 6.47M | 6.06M | 5.35M | 5.48M | 5.28M | 4.88M |
Other Working Capital | 4.4M | -3.19M | -1.21M | 4.63M | 1.32M | 1.7M | 1.8M | 8.72M | 2.68M | 1.45M | -6.27M | 4.85M | 290K | 5.57M | -11.01M | 274K | -522K | -7.25M | 15.67M | 282.85M | 292.53M | 401.6M | 1.05M |
Other Non-Cash Items | 1.42M | 1.03M | -1.94M | 1.51M | -1.93M | 1.16M | -1.18M | 1.06M | -823K | -279K | 1.06M | -7.09M | 519K | -1.04M | -339K | -30K | 146K | 54K | -474K | -71K | -2.19M | -213K | -1.03M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 546K | 345K | 560K | 525K | 431K |
Change in Working Capital | 2.93M | -49K | -2.88M | 5.38M | 32.3M | 2.11M | 113K | 9.16M | 2.7M | -3.35M | -1.38M | 6.21M | -1.23M | 17.01M | -13.97M | 3.36M | -6.37M | -130K | 9.93M | -2.86M | -10.15M | 11.04M | -11.72M |
Operating Cash Flow | -9.97M | -7.16M | -11.7M | -6.49M | 17.51M | -13.49M | -16.8M | -10.4M | -14.78M | -28.6M | -24.99M | -21.6M | -32.13M | -13.78M | -35.64M | -15.53M | -29.6M | -26.38M | -13.27M | -21.02M | -29.51M | -4.58M | -14.89M |
Capital Expenditures | -7K | -15K | -143K | -1.46M | -155K | -2.54M | -8.75M | -8.95M | -6.54M | -1.67M | -787K | -1.37M | -2.15M | -2.38M | -3.16M | -1.44M | -251K | -74K | -363K | -33K | -399K | -130K | -188K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.33M | n/a | n/a | -49.15M | -36.73M | -29.67M | -16.47M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -25.51M | -41.95M | -148.62M | -68.62M | -85.99M | -55.02M | n/a | 1K | -95.15M | -65.29M | -146.85M | -106.12M | -176.65M | -23.25M | -67.38M | -8.73M | -38.08M | -61.73M | -62.9M | 601K | -136.36M | -66.91M | -104.67M |
Sales Maturities Of Investments | 39.52M | 53.91M | 101.47M | 72.38M | 59.66M | 53.19M | 77.65M | 28.02M | 95.35M | 125.58M | 134.52M | 119.32M | 33.05M | 72.4M | 104.1M | 38.4M | 54.55M | 26.75M | 108.77M | 72.12M | 93.06M | 92.5M | 87.42M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.33M | n/a | n/a | 49.15M | 36.73M | 29.67M | 16.47M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 14.01M | 11.94M | -47.3M | 2.3M | -26.48M | -4.37M | 68.9M | 19.07M | -6.35M | 58.62M | -13.12M | 11.84M | -145.75M | 46.77M | 33.57M | 28.23M | 16.22M | -35.06M | 45.5M | 72.68M | -43.71M | 25.46M | -17.45M |
Debt Repayment | n/a | n/a | -5.86M | -26.49M | n/a | n/a | -4.94M | -7.26M | n/a | n/a | -7.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.54M | -7.34M | -97K | 18.11M | -6.33M | -6.89M | -137K | -19K | -6.68M | -6.47M | -183K | -23K | 199.88M | -2.03M | 301K | 2.93M | 4.12M | 3.35M | 9.63M | 943K | 686K | 1.15M | 299K |
Financial Cash Flow | -5.54M | -7.3M | 64.14M | -8.32M | -6.42M | -6.89M | -4.99M | -7.22M | -6.65M | -6.41M | -7.35M | -23K | 199.88M | -2.03M | 301K | 2.93M | 4.12M | 3.35M | 9.63M | 943K | 686K | 1.15M | 299K |
Net Cash Flow | 1.85M | -2.51M | 5.14M | -12.51M | -15.4M | -24.74M | 47.12M | 1.46M | -27.77M | 23.61M | -45.46M | -9.79M | 22M | 30.96M | -1.77M | 15.63M | -9.26M | -58.08M | 41.86M | 52.61M | -72.53M | 22.03M | -32.04M |
Free Cash Flow | -9.98M | -7.17M | -11.84M | -7.95M | 17.35M | -16.03M | -25.55M | -19.35M | -21.32M | -30.27M | -25.78M | -22.97M | -34.28M | -16.17M | -38.8M | -16.97M | -29.85M | -26.45M | -13.63M | -21.05M | -29.91M | -4.71M | -15.08M |
Adj. Free Cash Flow | -13.66M | -10.92M | -15.65M | -11.98M | 13.17M | -20.71M | -31.21M | -27.07M | -26.73M | -35.83M | -33.87M | -29.69M | -41.28M | -23.53M | -45.94M | -23.8M | -37.46M | -32.92M | -19.7M | -26.41M | -35.38M | -9.99M | -19.96M |
Maintenance CapEx | -7K | -15K | -143K | -1.28M | -37.38K | -2.54M | -8.75M | -8.95M | -6.54M | -1.67M | -787K | -1.37M | -2.15M | -2.38M | -3.16M | -1.44M | -251K | -74K | -363K | -33K | -195.04K | -130K | -188K |
Growth CapEx | n/a | n/a | n/a | -177.63K | -117.62K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -203.96K | n/a | n/a |
Owner Earnings | -9.98M | -7.17M | -11.84M | -7.77M | 17.47M | -16.03M | -25.55M | -19.35M | -21.32M | -30.27M | -25.78M | -22.97M | -34.28M | -16.17M | -38.8M | -16.97M | -29.85M | -26.45M | -13.63M | -21.05M | -29.7M | -4.71M | -15.08M |
Add to Watchlist
Select watchlists to add or remove ENTA